140 related articles for article (PubMed ID: 2535863)
21. Inhibition of collagen degradative enzymes by retinoic acid in vitro.
Bauer EA; Seltzer JL; Eisen AZ
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):603-7. PubMed ID: 6279711
[TBL] [Abstract][Full Text] [Related]
22. [Fibroblast collagenase activity in some types of inherited epidermolysis bullosa].
Nomura K; Imazumi T; Sato S; Hashimoto I; Katabira Y
Nihon Hifuka Gakkai Zasshi; 1986 Apr; 96(5):477-81. PubMed ID: 3016380
[No Abstract] [Full Text] [Related]
23. Stimulation of collagenase synthesis by a 20,000-dalton epithelial cytokine. Evidence for pretranslational regulation.
Johnson-Wint B; Bauer EA
J Biol Chem; 1985 Feb; 260(4):2080-5. PubMed ID: 2982807
[TBL] [Abstract][Full Text] [Related]
24. Assay of collagenase activity by a rapid, sensitive, and specific method.
Ryhänen L; Rantala-Ryhänen S; Tan EM; Uitto J
Coll Relat Res; 1982 Mar; 2(2):117-30. PubMed ID: 6286240
[TBL] [Abstract][Full Text] [Related]
25. Human skin collagenase: relationship to the pathogenesis of epidermolysis bullosa dystrophica.
Eisen AZ
J Invest Dermatol; 1969 May; 52(5):449-53. PubMed ID: 4305996
[No Abstract] [Full Text] [Related]
26. Epidermal factors stimulate collagenase synthesis by epidermolysis bullosa fibroblasts.
Nomura K; Takahashi M; Mikami H; Imaizumi T; Sawada Y; Hashimoto I
J Dermatol; 1988 Aug; 15(4):279-82. PubMed ID: 2848877
[No Abstract] [Full Text] [Related]
27. Retinoic acid inhibition of collagenase and gelatinase expression in human skin fibroblast cultures. Evidence for a dual mechanism.
Bauer EA; Seltzer JL; Eisen AZ
J Invest Dermatol; 1983 Aug; 81(2):162-9. PubMed ID: 6308104
[TBL] [Abstract][Full Text] [Related]
28. Enzyme-linked immunosorbent assay for human skin collagenase.
Cooper TW; Bauer EA; Eisen AZ
Coll Relat Res; 1983 May; 3(3):205-15. PubMed ID: 6191911
[TBL] [Abstract][Full Text] [Related]
29. Expression of collagenase and stromelysin in skin fibroblasts from recessive dystrophic epidermolysis bullosa.
Sato T; Nomura K; Hashimoto I
Arch Dermatol Res; 1995; 287(5):428-33. PubMed ID: 7625851
[TBL] [Abstract][Full Text] [Related]
30. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)].
Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I
Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283
[TBL] [Abstract][Full Text] [Related]
31. [The effect of collagenase inhibition on bullous eruption and healing process in epidermolysis bullosa].
Coradello H; Lubec G
Hautarzt; 1979 Feb; 30(2):89-91. PubMed ID: 217851
[TBL] [Abstract][Full Text] [Related]
32. Skin expression of metalloproteinases and tissue inhibitor of metalloproteinases in sibling patients with recessive dystrophic epidermolysis and intrafamilial phenotypic variation.
Bodemer C; Tchen SI; Ghomrasseni S; Séguier S; Gaultier F; Fraitag S; de Prost Y; Godeau G
J Invest Dermatol; 2003 Aug; 121(2):273-9. PubMed ID: 12880418
[TBL] [Abstract][Full Text] [Related]
33. Increased gene expression of matrix metalloproteinase-3 (stromelysin) in skin fibroblasts from patients with severe recessive dystrophic epidermolysis bullosa.
Sawamura D; Sugawara T; Hashimoto I; Bruckner-Tuderman L; Fujimoto D; Okada Y; Utsumi N; Shikata H
Biochem Biophys Res Commun; 1991 Jan; 174(2):1003-8. PubMed ID: 1704217
[TBL] [Abstract][Full Text] [Related]
34. Collagen synthesis and degradation by epidermolysis bullosa fibroblasts.
Oakley CA; Priestley GC
Acta Derm Venereol; 1985; 65(4):277-81. PubMed ID: 2413679
[TBL] [Abstract][Full Text] [Related]
35. Collagen metabolism in two rare forms of epidermolysis bullosa.
Kero M; Palotie A; Peltonen L
Br J Dermatol; 1984 Feb; 110(2):177-84. PubMed ID: 6320858
[TBL] [Abstract][Full Text] [Related]
36. Constitutive activation of the collagenase promoter in recessive dystrophic epidermolysis bullosa fibroblasts: role of endogenously activated AP-1.
Unemori EN; Mauch C; Hoeffler W; Kim Y; Amento EP; Bauer EA
Exp Cell Res; 1994 Apr; 211(2):212-8. PubMed ID: 8143767
[TBL] [Abstract][Full Text] [Related]
37. Epidermal neoplasms with epidermolysis bullosa dystrophica with the first report of carcinoma with the acquired type.
Reed WB; Roenigk H; Dorner W; Welsh O; Martin FJ
Arch Dermatol Res (1975); 1975 Aug; 253(1):1-14. PubMed ID: 172030
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic considerations in recessive dystrophic epidermolysis bullosa.
Bauer EA; Cooper TW
Arch Dermatol; 1981 Sep; 117(9):529-30. PubMed ID: 6271076
[No Abstract] [Full Text] [Related]
39. Collagen VII in severe recessive dystrophic epidermolysis bullosa: expression of mRNA but lack of intact protein product in skin and cutaneous cells in vitro.
Kalinke DU; Kalinke U; Winberg JO; König A; Lauharanta J; Christiano AM; Uitto J; Bruckner-Tuderman L
J Invest Dermatol; 1994 Feb; 102(2):260-2. PubMed ID: 8106757
[TBL] [Abstract][Full Text] [Related]
40. [In-vitro inhibition of collagenase activity in epidermolysis bullosa hereditaria dystrophica].
Ratzenhofer E; Lubec G; Kokoschka EM
Z Hautkr; 1978 Dec; 53(24):929-34. PubMed ID: 216174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
